《大行報告》瑞信升鐵塔(00788.HK)評級至「跑贏大市」 目標價下調至1.04元
瑞信發表報告指,中國鐵塔(00788.HK)將於本週三(19日)公佈今年第三季業績,估計集團收入、EBITDA及純利將分別按年增長6%、2.4%及11.9%,與第二季因疫情延長封城相比,增長更爲溫和。而塔類收入增長料爲低單位數。
該行下調鐵塔今年至2024年每股盈測介乎2%至3%,股份目標價由1.08元輕微調低至1.04元,但評級由「中性」升至「跑贏大市」,認爲集團股價8月底開始的跌幅達16%,是市場反應過度,因其業務性質穩定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.